Table 3.

Baseline demographic details of participants.

Demographics	Total (N = 13)	Treatment groups
		affron® 56 mg (n = 7)	affron® 84 mg (n = 6)
Mean age (SD)	23.6 (2.9)	23.0 (2.0)	24.6 (3.9)
Age range (years)	19–30	20–26	19–30
Gender (number, %)
Female	8 (61.5%)	4 (57.1%)	4 (66.6%)
Male	5 (38.5%)	3 (42.9%)	2 (33.4%)
Weight (SD)
Female	59.0 (4.2)	58.9 (3.7)	59.1 (4.8)
Male	83.2 (5.7)	82.9 (5.3)	83.6 (6.1)